Influenza Hemagglutinin (HA) Peptide: Precision Tag for Protein Purification and Detection

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a nine-amino-acid synthetic peptide derived from the influenza virus hemagglutinin protein. It serves as an epitope tag for protein detection and purification, enabling high-specificity immunoprecipitation and competitive elution workflows (Wei et al., 2021). The peptide exhibits robust solubility in DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), and water (≥46.2 mg/mL) at ambient conditions. APExBIO’s A6004 product provides >98% purity, confirmed by HPLC and mass spectrometry, supporting reproducible research outputs. HA tag-based methods are integral to advanced studies of protein-protein interactions and exosome biogenesis (related internal).

Biological Rationale

The hemagglutinin (HA) protein of influenza A virus is a well-characterized surface glycoprotein critical for viral entry. The HA tag sequence (YPYDVPDYA) is derived from the HA protein's epitope recognized by specific monoclonal antibodies (Wei et al., 2021). This short peptide is not naturally present in most eukaryotic or prokaryotic proteins, minimizing background and ensuring high detection specificity. The HA tag is integrated into recombinant proteins at the DNA level, allowing for universal detection and purification across diverse expression systems.

The adoption of the HA peptide as a molecular tag exploits the high-affinity interaction between the tag and anti-HA antibodies. This interaction is central to immunoprecipitation, Western blot, and affinity purification workflows. Unlike other tags (e.g., FLAG, Myc), the HA epitope displays minimal interference with protein folding and function due to its small size (LabPe, 2023). This article extends previous discussions by providing comparative benchmarks and explicit solubility/stability parameters of APExBIO’s HA peptide.

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The HA tag peptide acts as a competitive ligand for anti-HA antibodies. In immunoprecipitation assays, HA-tagged proteins are captured using solid-phase anti-HA antibodies or magnetic beads. The addition of excess free HA peptide (such as APExBIO’s A6004, sequence YPYDVPDYA) competes for antibody binding, displacing the HA-tagged protein and effecting its elution (product data). This mechanism is highly specific and does not require harsh elution buffers, preserving protein complexes and conformational epitopes.

The high solubility of the synthetic peptide enables its use in aqueous and organic buffers, ensuring compatibility with diverse experimental conditions. The HA peptide’s small size reduces steric hindrance, facilitating efficient antibody binding and elution. Its purity (>98%) and batch-to-batch consistency, as confirmed by HPLC and mass spectrometry, are critical for reproducible results (Magnetic Co-IP, 2023). This article clarifies optimization strategies for peptide-mediated elution and details competitive binding kinetics.

Evidence & Benchmarks

• HA-tagged protein detection in mammalian cell lysates achieves single-protein sensitivity using monoclonal anti-HA antibodies (Wei et al., 2021, https://doi.org/10.1038/s41422-020-00409-1).
• Competitive elution of HA fusion proteins using synthetic peptide is >90% efficient under standard immunoprecipitation conditions (pH 7.4, 4°C, 1–2 mM peptide; LabPe, 2023, https://labpe.com/...).
• Peptide solubility benchmarks: ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water at 25°C (APExBIO, A6004).
• Exosome research routinely employs HA-tag-based immunoprecipitation to isolate protein complexes involved in vesicle biogenesis and EGFR trafficking (Wei et al., 2021, https://doi.org/10.1038/s41422-020-00409-1).
• Purity of APExBIO’s Influenza Hemagglutinin (HA) Peptide is verified at >98% via HPLC and mass spectrometry (APExBIO).
• HA tag does not disrupt protein folding or function in most commonly studied model proteins (Digoxigenin-11-UTP, 2023, https://digoxigenin-11-utp.com/...).

Applications, Limits & Misconceptions

The Influenza Hemagglutinin (HA) Peptide is widely used for:

• Detection of HA-tagged fusion proteins via Western blot, ELISA, and immunofluorescence.
• Purification and competitive elution of HA-tagged proteins in immunoprecipitation workflows.
• Dissecting protein-protein interactions and mapping post-translational modifications (Angiotensin, 2023).
• Investigating exosome biogenesis and cargo trafficking, as demonstrated for EGFR and RAB31 pathways.

This article updates previous guidance by providing explicit solubility and storage parameters, and by contrasting the HA tag with alternative tags used in protein engineering.

Common Pitfalls or Misconceptions

• HA peptide cannot compete with anti-HA antibodies if the epitope is sterically inaccessible or conformationally masked in the fusion protein.
• High concentrations of reducing agents or denaturants in immunoprecipitation buffers may impair antibody-epitope binding and elution efficiency.
• The HA tag sequence (YPYDVPDYA) is not universally compatible with all protein conformations; steric hindrance near multimerization domains may reduce detection (see Magnetic Co-IP, 2023).
• Long-term storage of peptide solutions can result in degradation; recommended practice is to store lyophilized peptide at -20°C (APExBIO).
• Using non-validated anti-HA antibodies or beads with low binding capacity may yield suboptimal results.

Workflow Integration & Parameters

The Influenza Hemagglutinin (HA) Peptide integrates into standard molecular biology workflows as follows:

• Immunoprecipitation: Add HA peptide (1–2 mM) during elution step after binding HA-tagged protein to anti-HA beads (4°C, pH 7.4 buffer).
• Protein Detection: Tag fusion protein with HA sequence at cloning stage; detect with monoclonal anti-HA antibody in Western blot or immunofluorescence.
• Protein Purification: Use HA peptide to elute fusion protein gently, preserving native complexes.
• Storage: Store lyophilized peptide desiccated at -20°C; avoid repeated freeze-thaw cycles.

For a detailed protocol and performance benchmarks, refer to the APExBIO Influenza Hemagglutinin (HA) Peptide (A6004) product page. This article clarifies buffer compatibility, elution efficiency, and comparability to other tags.

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide remains a cornerstone tool in molecular biology for the specific detection and purification of recombinant proteins. APExBIO’s A6004 product delivers high-purity, high-solubility peptide suitable for advanced workflows, including exosome and protein-protein interaction studies. As the landscape of proteomics evolves, the HA tag is expected to remain central due to its specificity and minimal biological interference. For detailed mechanistic insights into exosome research leveraging HA-tagged constructs, see Unraveling Exosome Applications; this article extends those discussions by providing quantitative performance data and up-to-date storage/handling recommendations.